Most-favored-nation pricing could save Medicaid $8.6B: Study

A recent study published in JAMA suggests that adopting most-favored-nation pricing for Medicaid drug purchases could save 47 states and D.C. a whopping $8.6 billion, representing about 35% of their current drug spending. This strategy would involve setting prices based on what other wealthy nations pay, potentially leading to significant cost reductions. The research, spearheaded by Thomas Hwang of Brigham and Women’s Hospital, underscores the potential for substantial savings in Medicaid spending, which could otherwise be redirected towards other critical healthcare needs.